HSA Grants Interim Authorisation for Evusheld for Pre-exposure Prevention of COVID-19 in Adults who are Medically Unsuitable for Vaccination
The Health Sciences Authority (HSA), in consultation with its Medicines Advisory Committee, has, on 1 August 2022, granted an interim authorisation under the Pandemic Special Access Route (PSAR) for AstraZeneca’s…